It is well known that thyroxine (T4) is bound to throxine binding globulin (TBG), thyroxine-binding prealbumin (TBPA) and albumin in normal human serum. Literatures indicate that TBG may play a predominant role in thyroxine transport due to its high affinity for thyroxine, although TBG concentration in serum is the lowest in comparison with the other T4-binding proteins (Ingbar & Freinkel, 1960; Osorio, 1962; Hamada et al., 1970) .
Evidence has been accumulated that changes in TBG content occur in various disorders of thyroid function and in non-thyroidal illnesses and physiological states. For example, TBG content is increased in pregnancy (Robbins & Nelson., 1958; Nicoloff et al., 1970 ; Refetoff et al., 1972) , during estrogen therapy (Levy et al., 1971; Refetoff et al., 1972) and in an inherited trait (Levy et al., 1971) . On the contrary TBG content is decreased in the patient with liver cirrhosis (Levy et al., 1971) , nephrosis (Musa et al., 1967) , acute and chronic illness (Refetoff et al., 1972) and in an inherited TBG deficient trait (Levy et al., 1971) . Several methods for the determination of the maximal binding capacity of TBG (max. TBG), electrophoretic separation of serum protein (Albright et al., 1955; Sterling (Keane et al., 1969; Refetoff et al., 1972) , have been reported. 131 I-T3 resin sponge uptake (T3 RSU or Triosorb; Dainabot RI Laboratory), a popular test of thyroid function is proportional to the degree of the unsaturated binding capacity of TBG. It has been previously indicated that the reciprocal value of T3 RSU showed a positive correlation with the unsaturated binding capacity of TBG (Hamada et al., 1970; Nicoloff et al., 1970 (Fig.1) .
The intercept at the ordinate proved to be 1, as theoretically suggested and the slope 0.171. Therefore the relation between the reciprocal value of T3 RSU (Y) and the unsaturated binding capacity of TBG (X) could be obtained by substitution of these values in equation 3 or equation 4. Relationship between the reciprocal values of T3 RSU and the unsaturated binding capacity of TBG measured by saturation method, in patients with myxedema.
Triosorb results were expressed as a fraction rather than percent, therefore the ordinate (1/U) is greater than 1. T3 RSU is used as The unsaturated binding capacity of TBG in various thyroidal diseases was calculated using the equations 5 and 6. In patients with high endogenous T4, usually a larger proportion of the total endogenous T4 is bound to albumin and TBPA, and the endogenous TBG is oversaturated limiting the sensitivity of T3 RSU test. Accordingly the endogeneous T4 should be removed. Using DCC solution, 70% of endogeneous T4 was removed from T4-binding protein in serum, which is described in method section. The Triosorb test was performed with sera that had been treated with DCC. The unsaturated binding capacity of TBG of sera was determined from the Triosorb value using equation 6. Accordingly, max. TBG was calculated as follows : Max. TBG=unsaturated binding capacity of TBG
Of course when the myxedematous sera are used for TBG determination, the procedure of DCC treatment is unnecessary and max. TBG is calculated by the addition of the endogenous T4 value (determined by Tetrasorb procedure) to the unsaturated binding capacity of TBG.
Materials
All test sera were obtained from patients and normal volunteers. Diagnosis was made from clinical signs and laboratory data. Triosorb (T3 RSU) and Tetrasorb (T4 determination by competitive binding assay) measurements were made using commercial kits obtained form Dainabot Laboratory (Tokyo Japan). Normal values for T3 RSU and T4 in our laboratory were 25-35% and 5.4-13.7 pg T4/100ml respectively. All radioactive materials were purchased from Abbott Laboratory (Chicago, U.S.A.). The percent of extractable 131 I_T4 from test. serum with 131 I-T4 by DCC solution. The abscissa. expressed the ratio of DCC solution in amount (ml) divided by serum volume (ml).
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Estimating the change of TBG in quality by DCC treatment, 1.0ml of DCC solution was given to pooled human serum of 1.0ml with tracer amounts of an 131 I-T4 solution. Protein concentration was determined by ultra-violet absorption at 280mp. A three percent decrease in serum protein was observed after treatment with DCC solution. In an other experiment 1.0ml of DCC solution was added to pooled human serum of 0.1ml with tracer amounts of a 125 I-RISA (Radioiodinated serum albumin) and the fraction of RISA removed from serum was determined. In 3 experiments, less than 5% of RISA was removed.
In general, albumin of which molecular weight is low compared with globulins in serum is easily absorbed to DCC (Ochi et al., 1973) . The molecular weight of TBG is close to that of albumin, so the fraction of TBG removed by DCC treatment is thought to be under 5%.
Results
To evaluate the DCC treatment, max. TBG in sera from hypothyroid patients and from pregnant women was determined with and without DCC treatment (Table 1) . The difference in the max. TBG determined by these two hypothyroid series of patients was less than 8%.
In two pregnant subjects having less than 25% in the T3 RSU, max. TBG was determined with or without DCC treatment. There was less than 5% difference in the values by either method.
To assess the applicability of the equations 5 and 6 to the non-myxedematous thyroid state, max. TBG in serum from 3 patients or higher than in hyperthyroidism. In other thyroid diseases (simple goiter, thyroid cancer and Hashimoto's thyroiditis) it was also within the normal range (Fig.3) .
The 8 hyperthyroid patients max. TBG was examined after symptoms had returned to a euthyroid level. As shown in Fig.4 , max. TBG decreased in half the patients but not in the rest.
A longitudinal study showing changes in max. TBG during pregnancy in a single thyrotoxic patient is shown in Fig.5 
Discussion
In the electrophoretic saturation methods for the measurement of T4 binding capacity of TBG, excess T4 is added to the test serum usually in concentrations of 100 or 200pg/100 ml (Albright et al., 1955; Nikolae & Seal, 1966) . Under these conditions TBG is fully saturated.
The amount of T4 bound to TBG is derived by examining the percentage of the radioactive T4 in the TBG region on electrophoresis. From our personal experience we know that it is difficult to obtain accurate values by the saturation method with conventional electrophoretic separation, because of nonspecific binding of T4 to proteins and poor reproducibility.
Recently methods for the estimation of the T4 binding capacity of TBG by non-electrophoretic procedures using either DCC (Roberts & Nikolai, 1969) or ion-exchange resin (Keane et al., 1969; Refetoff et al., 1972) , competitive ligand-binding assay (Chopra et al., 1972) and radioimmunoassay of TBG (Levy et al., 1971) have been reported and these procedures were limited in some ways.
Attempts to determine the normal distribution of endogenous T4 among serum binding protein utilizing the saturation method have yielded inconsistent results. For instance, a distribution of 83% for TBG, 2% for TBPA, 10% for albumin and 5% for others has been reported (Osorio, 1962) , contrasted to 76%, 15% and 9% (Hamada et al., 1970) or 45%, 40% and 15% (Ingbar & Freikel, 1960) for TBG, TBPA and albumin respectively. Therefore it is not clear whether the percentage of T4 distribution among carrier protiens determined by various electrophoretic methods actually reflects the situation in of T4 to TBG or TBPA or albumin in human serum was changed by experimental pH conditions (Lutz & Gregerman, 1967; Coutsoftides & Gordon, 1970) . In the present state of knowledge the physiological role of TBPA in the transport of T4 remains unclear.
In sera from patients with myxedema T4 binding to TBPA and albumin is so low that binding to other carrier proteins than TBG can be neglected for practical purposes.
In the present procedure, 70% of the endogenous T4 in sera was removed by DCC, creating an analogous situation to that present in the serum from hypothyroid patients. The loss of TBG quantity by DCC treatment was within 5%, which could be neglected in practical use. Under these conditions it is therefore legitimate to calculate the unsaturated binding capacity of TBG utilizing the reciprocal value of T3 RSU and the equation derived. Max. TBG can be obtained from the arithmetic sum of the unsaturated binding capacity of TBG and the concentration of residual T4 in the serum treated by DCC. The residual T4 after the extraction procedure by DCC accounts for 30% of original serum T4 level determined by Tetrasorb method. When T3 RSU was less than 25% in hypothyroid patients, max. TBG showed no significant difference by the method, with or without DCC treatment.
The values obtained by the present method in euthyroid subjects and patients with various thyroidal diseases are compatible with thos previously reported (Albright et al., 1955; Robbins & Rall, 1957; Roberts & Nikolai, 1969 ; Refetoff et al., 1972) . Using the saturation method with electrophoretic separation, a decreased max. TBG was observed in some cases of hyperthyroidism, especially when endogenous T4 levels exceeded max.
TBG. An elevated max. TBG was observed in hypothyroidism (Albright et al., 1955; Robbins & Rall, 1957; Ingbar & Freinkel, 1960) . In contrast, TBG levels were normal in hypothyroidism and slightly lower in hyperthyroidism using the radioimmunoassay (Levy et al., 1971) . In the present procedure, Levy et al.(1971) (using radioimmunoassay) and Chopra et al.(1972) (using a radioligand method) have reported that the low binding capacity in hyperthyroid patients gradually increase after treatment. From the presnt study,the half of the8 patients with hyperthyroidism showed an increase of binding capacity of TBG, and in the rest it was almost the same. The present method requires the T3 RSU test and DCC technique.
Therefore, it has some technical limitations like other non-electrophretic techniques, but it can be used for measuring binding capacity of TBG with accuracy.
